Companion Animals

Myasthenia Gravis in Dogs: 2025 Welfare and Management

Updated welfare guide for canine myasthenia gravis -- a neuromuscular disease causing weakness and regurgitation.

Key Facts

Myasthenia gravis (MG) is an immune-mediated neuromuscular disease causing progressive muscle weakness
It results from autoantibodies against acetylcholine receptors at the neuromuscular junction
Oesophageal dysfunction (megaoesophagus) causing regurgitation is the most common presenting sign
Aspiration pneumonia from regurgitation is the most common cause of death in MG dogs
Some dogs show only oesophageal involvement while others have generalised weakness
Diagnosis requires acetylcholine receptor antibody testing -- a specific blood test
Pyridostigmine and immunosuppressive therapy are the treatments of choice
Bailey chairs -- devices that keep dogs upright after eating -- reduce aspiration risk and are a critical welfare tool

Welfare Significance

Myasthenia gravis welfare management revolves around preventing aspiration pneumonia -- the most dangerous welfare complication. Bailey chairs, small frequent meals, and keeping dogs upright after feeding are practical welfare interventions that owners can implement. Dogs with MG can live comfortable lives with appropriate management. Early diagnosis and treatment before severe aspiration occurs dramatically improves welfare outcomes.

What You Can Do

Seek veterinary investigation for any dog with recurrent regurgitation -- aspiration pneumonia risk makes this urgent
Test for acetylcholine receptor antibodies in any dog with unexplained generalised weakness
Build or buy a Bailey chair for MG dogs to reduce aspiration pneumonia risk after feeding
Monitor for respiratory signs indicating aspiration pneumonia -- prompt treatment is life-saving